A new enzyme immunoassay for the determination of highly sialylated and fucosylated human α1-acid glycoprotein as a biomarker of tumorigenesis

Conclusions α1,3fucosylated AGP is a potential biomarker of cancer initiation, progression and response to treatment in cancer patients.
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research